Blue Route Technologies for Neurodevelopment
PrivateLast Round
Accelerator
Oct 31, 2024
Total Funding Raised
$510,000
Company Overview
Blue Route Technologies for Neurodevelopment operates in Healthcare & Life Sciences and is based in Gijón. Its latest recorded funding round was an Accelerator round in October 2024.
Blue Route Technologies for Neurodevelopment is a digital health company that provides AI-powered solutions for the early screening, diagnosis, and personalized digital therapy of neurodevelopmental disorders, with a primary focus on Autism Spectrum Disorder.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Mental Health, Vertical SaaS
Business Model
B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Blue Route Technologies for Neurodevelopment Comparables
Compare Blue Route Technologies for Neurodevelopment with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cognoa | 78% | |
| EarliPoint Health | 69% | |
| Limbic | 52% |
For institutional investors. Book with your work email.
Blue Route Technologies for Neurodevelopment Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 31, 2024
$50K raised from Goo Ventures and GooApps.
For institutional investors. Book with your work email.
Blue Route Technologies for Neurodevelopment Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Blue Route Technologies for Neurodevelopment's valuation, stock price, and market status.
Is Blue Route Technologies for Neurodevelopment a public or private company?
Blue Route Technologies for Neurodevelopment is a private company.
What is the current stock price of Blue Route Technologies for Neurodevelopment?
Blue Route Technologies for Neurodevelopment is a private company, so its shares have no public market price. Caplight tracks Blue Route Technologies for Neurodevelopment's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Blue Route Technologies for Neurodevelopment worth (valuation)?
Valuation information for Blue Route Technologies for Neurodevelopment is not publicly available.
Can I buy Blue Route Technologies for Neurodevelopment stock?
Blue Route Technologies for Neurodevelopment shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Blue Route Technologies for Neurodevelopment's last funding round?
Blue Route Technologies for Neurodevelopment's most recent funding round was Accelerator on October 31, 2024.
Who are the main investors in Blue Route Technologies for Neurodevelopment?
Investor information for Blue Route Technologies for Neurodevelopment is not publicly disclosed.
Will Blue Route Technologies for Neurodevelopment IPO soon?
No public IPO plans have been announced for Blue Route Technologies for Neurodevelopment.
How can I track Blue Route Technologies for Neurodevelopment secondary market activity?
Caplight tracks bids, offers, and trades in Blue Route Technologies for Neurodevelopment's shares on secondary markets.